Raleigh Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2K | Sell |
84
-5
| -6% | -$2.03K | 0.01% | 292 |
|
|
2025
Q1 | $44.4K | Sell |
89
-109
| -55% | -$54.4K | 0.02% | 280 |
|
|
2024
Q4 | $103K | Sell |
198
-6
| -3% | -$3.13K | 0.04% | 245 |
|
|
2024
Q3 | $126K | Sell |
204
-5
| -2% | -$3.1K | 0.05% | 237 |
|
|
2024
Q2 | $116K | Buy |
209
+31
| +17% | +$17.2K | 0.05% | 237 |
|
|
2024
Q1 | $104K | Buy |
178
+74
| +71% | +$43K | 0.04% | 239 |
|
|
2023
Q4 | $55K | Buy |
104
+22
| +27% | +$11.6K | 0.03% | 276 |
|
|
2023
Q3 | $41.3K | Buy |
82
+27
| +49% | +$13.6K | 0.02% | 281 |
|
|
2023
Q2 | $28.7K | Sell |
55
-24
| -30% | -$12.5K | 0.01% | 321 |
|
|
2023
Q1 | $45.6K | Buy |
79
+55
| +229% | +$31.7K | 0.02% | 258 |
|
|
2022
Q4 | $13.2K | Buy |
24
+7
| +41% | +$3.86K | 0.01% | 382 |
|
|
2022
Q3 | $9K | Buy |
17
+6
| +55% | +$3.18K | 0.01% | 390 |
|
|
2022
Q2 | $6K | Hold |
11
| – | – | ﹤0.01% | 428 |
|
|
2022
Q1 | $7K | Buy |
+11
| New | +$7K | ﹤0.01% | 424 |
|